Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Left Ventricular Hypertrophy in Rhesus Macaques (Macaca mulatta) at the California National Primate Research Center (1992-2014).

Reader JR, Canfield DR, Lane JF, Kanthaswamy S, Ardeshir A, Allen AM, Tarara RP.

Comp Med. 2016 Apr;66(2):162-9.

PMID:
27053572
2.

Cardiac troponin structure-function and the influence of hypertrophic cardiomyopathy associated mutations on modulation of contractility.

Cheng Y, Regnier M.

Arch Biochem Biophys. 2016 Jul 1;601:11-21. doi: 10.1016/j.abb.2016.02.004. Epub 2016 Feb 4.

PMID:
26851561
3.

A Novel Method of Determining the Functional Effects of a Minor Genetic Modification of a Protein.

Nagwekar J, Duggal D, Midde K, Rich R, Liang J, Kazmierczak K, Huang W, Fudala R, Gryczynski I, Gryczynski Z, Szczesna-Cordary D, Borejdo J.

Front Cardiovasc Med. 2015 Nov 18;2:35. doi: 10.3389/fcvm.2015.00035. eCollection 2015.

4.

Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: From Experiment to Standard of Care.

Faber L.

Adv Med. 2014;2014:464851. doi: 10.1155/2014/464851. Epub 2014 May 6. Review.

5.

Investigating the Mechanism of Hyperglycemia-Induced Fetal Cardiac Hypertrophy.

Han SS, Wang G, Jin Y, Ma ZL, Jia WJ, Wu X, Wang XY, He MY, Cheng X, Li WJ, Yang X, Liu GS.

PLoS One. 2015 Sep 29;10(9):e0139141. doi: 10.1371/journal.pone.0139141. eCollection 2015.

6.

Molecular mechanisms of cardiomyopathy phenotypes associated with myosin light chain mutations.

Huang W, Szczesna-Cordary D.

J Muscle Res Cell Motil. 2015 Dec;36(6):433-45. doi: 10.1007/s10974-015-9423-3. Epub 2015 Sep 18.

PMID:
26385864
7.

Myosin light chains: Teaching old dogs new tricks.

Heissler SM, Sellers JR.

Bioarchitecture. 2014;4(6):169-88. doi: 10.1080/19490992.2015.1054092. Review.

8.

Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice.

Yuan CC, Muthu P, Kazmierczak K, Liang J, Huang W, Irving TC, Kanashiro-Takeuchi RM, Hare JM, Szczesna-Cordary D.

Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):E4138-46. doi: 10.1073/pnas.1505819112. Epub 2015 Jun 29.

9.

Synchronous cardiac arrest in monozygotic twins with hypertrophic cardiomyopathy--is sudden cardiac death genetically pre-programmed?

Goh CY, Asrar ul Haq M, Mutha V, van Gaal WJ.

BMC Cardiovasc Disord. 2015 Feb 28;15:16. doi: 10.1186/s12872-015-0007-3.

10.

Effect of a myosin regulatory light chain mutation K104E on actin-myosin interactions.

Duggal D, Nagwekar J, Rich R, Huang W, Midde K, Fudala R, Das H, Gryczynski I, Szczesna-Cordary D, Borejdo J.

Am J Physiol Heart Circ Physiol. 2015 May 15;308(10):H1248-57. doi: 10.1152/ajpheart.00834.2014. Epub 2015 Mar 13.

11.

Hypertrophic cardiomyopathy: a review.

Houston BA, Stevens GR.

Clin Med Insights Cardiol. 2015 Jan 26;8(Suppl 1):53-65. doi: 10.4137/CMC.S15717. eCollection 2014. Review.

12.

Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice.

Barefield D, Kumar M, Gorham J, Seidman JG, Seidman CE, de Tombe PP, Sadayappan S.

J Mol Cell Cardiol. 2015 Feb;79:234-43. doi: 10.1016/j.yjmcc.2014.11.018. Epub 2014 Nov 25.

13.

Compound heterozygous or homozygous truncating MYBPC3 mutations cause lethal cardiomyopathy with features of noncompaction and septal defects.

Wessels MW, Herkert JC, Frohn-Mulder IM, Dalinghaus M, van den Wijngaard A, de Krijger RR, Michels M, de Coo IF, Hoedemaekers YM, Dooijes D.

Eur J Hum Genet. 2015 Jul;23(7):922-8. doi: 10.1038/ejhg.2014.211. Epub 2014 Oct 22.

14.

Remodeling of the heart in hypertrophy in animal models with myosin essential light chain mutations.

Kazmierczak K, Yuan CC, Liang J, Huang W, Rojas AI, Szczesna-Cordary D.

Front Physiol. 2014 Sep 22;5:353. doi: 10.3389/fphys.2014.00353. eCollection 2014.

15.

Hypertrophic cardiomyopathy associated Lys104Glu mutation in the myosin regulatory light chain causes diastolic disturbance in mice.

Huang W, Liang J, Kazmierczak K, Muthu P, Duggal D, Farman GP, Sorensen L, Pozios I, Abraham TP, Moore JR, Borejdo J, Szczesna-Cordary D.

J Mol Cell Cardiol. 2014 Sep;74:318-29. doi: 10.1016/j.yjmcc.2014.06.011. Epub 2014 Jun 30.

16.

Epigenomes: the missing heritability in human cardiovascular disease?

Monte E, Vondriska TM.

Proteomics Clin Appl. 2014 Aug;8(7-8):480-7. doi: 10.1002/prca.201400031. Review.

17.

β-Myosin heavy chain variant Val606Met causes very mild hypertrophic cardiomyopathy in mice, but exacerbates HCM phenotypes in mice carrying other HCM mutations.

Blankenburg R, Hackert K, Wurster S, Deenen R, Seidman JG, Seidman CE, Lohse MJ, Schmitt JP.

Circ Res. 2014 Jul 7;115(2):227-37. doi: 10.1161/CIRCRESAHA.115.303178. Epub 2014 May 14.

18.

Altered interactions between cardiac myosin binding protein-C and α-cardiac actin variants associated with cardiomyopathies.

Chow ML, Shaffer JF, Harris SP, Dawson JF.

Arch Biochem Biophys. 2014 May 15;550-551:28-32. doi: 10.1016/j.abb.2014.04.003. Epub 2014 Apr 13.

20.

Allosteric effects of cardiac troponin TNT1 mutations on actomyosin binding: a novel pathogenic mechanism for hypertrophic cardiomyopathy.

Moore RK, Abdullah S, Tardiff JC.

Arch Biochem Biophys. 2014 Jun 15;552-553:21-8. doi: 10.1016/j.abb.2014.01.016. Epub 2014 Jan 28.

Items per page

Supplemental Content

Write to the Help Desk